Back
Salesforce Vs. NovoCure Industry Stock Comparison
Buy
59
CRM
Salesforce
Last Price:
360.43
Seasonality Move:
8.91%
Buy
77
NVCR
NovoCure
Last Price:
28.80
Seasonality Move:
2.04%
Buy
59
Salesforce (CRM)
is a Buy
Is Salesforce a Buy, Sell or Hold?
- The current Salesforce [CRM] share price is $331.43. The Score for CRM is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
- CRM is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
77
NovoCure (NVCR)
is a Buy
Is NovoCure a Buy, Sell or Hold?
- The current NovoCure [NVCR] share price is $30.51. The Score for NVCR is 77, which is 54% above its historic median score of 50, and infers lower risk than normal.
- NVCR is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
CRM Stock Price Chart
What is Salesforce's stock price today?
-
The Salesforce share price today is $331.43
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CRM is experiencing buying pressure, which is a positive indicator for future bullish movement.
NVCR Stock Price Chart
CRM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 9.39 | Buy |
| Relative Strength Index (14 RSI): | 59.26 | Buy |
| Chaikin Money Flow: | 7046343 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (305 - 339.16) | Buy |
| Bollinger Bands (100): | (248.67 - 308.43) | Buy |
NVCR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.24 | Buy |
| Relative Strength Index (14 RSI): | 84.56 | Buy |
| Chaikin Money Flow: | -690353 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (14.69 - 22.01) | Buy |
| Bollinger Bands (100): | (15.44 - 20.28) | Buy |
CRM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 335.32 | Sell |
| 20-day SMA: | 328.63 | Buy |
| 50-day SMA: | 302.94 | Buy |
| 200-day SMA: | 277.57 | Buy |
| 8-day EMA: | 332.27 | Sell |
| 20-day EMA: | 325.68 | Buy |
| 50-day EMA: | 306.74 | Buy |
| 200-day EMA: | 275.37 | Buy |
NVCR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 21.45 | Buy |
| 20-day SMA: | 18.85 | Buy |
| 50-day SMA: | 17.12 | Buy |
| 200-day SMA: | 17.34 | Buy |
| 8-day EMA: | 23.1 | Buy |
| 20-day EMA: | 19.92 | Buy |
| 50-day EMA: | 18.23 | Buy |
| 200-day EMA: | 19.07 | Buy |
Salesforce Earnings Growth & CRM Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.29 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.27 per share, and an increase next year of $1.91 per share.
NovoCure Earnings Growth & NVCR Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.71 per share, and a decrease next year of $0.32 per share.
Salesforce Technical Analysis
| Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | Nov 27 | Nov 29 | Dec 2 | Dec 3 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 19 | 20 | 21 | 22 | 25 | 26 | 27 | 29 | 02 | 03 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
NovoCure Technical Analysis
| Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | Nov 27 | Nov 29 | Dec 2 | Dec 3 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 19 | 20 | 21 | 22 | 25 | 26 | 27 | 29 | 02 | 03 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||